The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases.

about

The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases.

Item

http://www.wikidata.org/entity/Q39198820

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The utility of comprehensive a ...... l lung disease subgroup cases.

@en

The utility of comprehensive a ...... l lung disease subgroup cases.

@nl

type

Item

label

The utility of comprehensive a ...... l lung disease subgroup cases.

@en

The utility of comprehensive a ...... l lung disease subgroup cases.

@nl

prefLabel

The utility of comprehensive a ...... l lung disease subgroup cases.

@en

The utility of comprehensive a ...... l lung disease subgroup cases.

@nl

P1476

The utility of comprehensive a ...... l lung disease subgroup cases.

@en

P2093

Caroline V Cotton

http://www.w3.org/2001/XMLSchema#string

Lisa G Spencer

http://www.w3.org/2001/XMLSchema#string

Robert G Cooper

http://www.w3.org/2001/XMLSchema#string

Robert P New

http://www.w3.org/2001/XMLSchema#string

P2860

Classification and natural history of the idiopathic interstitial pneumonias

Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.

P304

1264-1271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEW320

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28339528

http://www.w3.org/2001/XMLSchema#string

P921

connective tissue

autoantibody

P932

5850114

http://www.w3.org/2001/XMLSchema#string